N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide (BioDeep_00000388888)

   


代谢物信息卡片


N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide

化学式: C26H33NO2 (391.25111580000004)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)Nc1ccc(O)cc1
InChI:



数据库引用编号

2 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Benjamin T Bikman, Yuguang Guan, Guanghou Shui, M Mobin Siddique, William L Holland, Ji Yun Kim, Gemma Fabriàs, Markus R Wenk, Scott A Summers. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis. The Journal of biological chemistry. 2012 May; 287(21):17426-17437. doi: 10.1074/jbc.m112.359950. [PMID: 22474281]
  • Aintzane Apraiz, Jolanta Idkowiak-Baldys, Naiara Nieto-Rementería, María Dolores Boyano, Yusuf A Hannun, Aintzane Asumendi. Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death. Biochemistry and cell biology = Biochimie et biologie cellulaire. 2012 Apr; 90(2):209-23. doi: 10.1139/o2012-001. [PMID: 22428532]
  • E A Roundhill, S A Burchill. Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria. British journal of cancer. 2012 Mar; 106(6):1224-33. doi: 10.1038/bjc.2012.40. [PMID: 22353810]
  • Roberta Carosio, Vito Pistoia, Isabella Orienti, Franca Formelli, Elena Cavadini, Salvatore Mangraviti, Paolo G Montaldo, Emanuela Ognio, Laura Emionite, Guendalina Zuccari. Enhanced anti-neuroblastoma activity of a fenretinide complexed form after intravenous administration. The Journal of pharmacy and pharmacology. 2012 Feb; 64(2):228-36. doi: 10.1111/j.2042-7158.2011.01403.x. [PMID: 22221098]
  • Justyna Szumiło, Justyna Podlodowska, Wiktor Podlodowski, Elzbieta Starosławska, Franciszek Burdan. [Chemoprevention of oral cancer--clinical and experimental studies]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 2012 Feb; 32(188):138-42. doi: ". [PMID: 22590920]
  • Debora Macis, Sara Gandini, Aliana Guerrieri-Gonzaga, Harriet Johansson, Paolo Magni, Massimiliano Ruscica, Matteo Lazzeroni, Davide Serrano, Massimiliano Cazzaniga, Serena Mora, Irene Feroce, Maria Pizzamiglio, Maria Teresa Sandri, Marcella Gulisano, Bernardo Bonanni, Andrea Decensi. Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Jan; 30(2):151-7. doi: 10.1200/jco.2011.35.2237. [PMID: 22162577]
  • In-uk Koh, Hye-Seung Jun, Joo Sun Choi, Joo Hyun Lim, Won Ho Kim, Jong Bok Yoon, Jihyun Song. Fenretinide ameliorates insulin resistance and fatty liver in obese mice. Biological & pharmaceutical bulletin. 2012; 35(3):369-75. doi: 10.1248/bpb.35.369. [PMID: 22382323]
  • Eugenia Poliakov, Alexander Gubin, James Laird, Susan Gentleman, Robert G Salomon, T Michael Redmond. The mechanism of fenretinide (4-HPR) inhibition of β-carotene monooxygenase 1. New suspect for the visual side effects of fenretinide. Advances in experimental medicine and biology. 2012; 723(?):167-74. doi: 10.1007/978-1-4614-0631-0_23. [PMID: 22183330]
  • William W Li, Vincent W Li, Michelle Hutnik, Albert S Chiou. Tumor angiogenesis as a target for dietary cancer prevention. Journal of oncology. 2012; 2012(?):879623. doi: 10.1155/2012/879623. [PMID: 21977033]
  • Jenny Wegert, Sabrina Bausenwein, Susanne Kneitz, Sabine Roth, Norbert Graf, Eva Geissinger, Manfred Gessler. Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro. Molecular cancer. 2011 Nov; 10(?):136. doi: 10.1186/1476-4598-10-136. [PMID: 22067876]
  • Judith G Villablanca, Wendy B London, Arlene Naranjo, Patrick McGrady, Matthew M Ames, Joel M Reid, Renee M McGovern, Sarah A Buhrow, Hollie Jackson, Enno Stranzinger, Brenda J Kitchen, Paul M Sondel, Marguerite T Parisi, Barry Shulkin, Gregory A Yanik, Susan L Cohn, C Patrick Reynolds. Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Nov; 17(21):6858-66. doi: 10.1158/1078-0432.ccr-11-0995. [PMID: 21908574]
  • Nishant Mohan, Naren L Banik, Swapan K Ray. Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells. Neuroscience letters. 2011 Sep; 502(1):24-9. doi: 10.1016/j.neulet.2011.07.016. [PMID: 21801811]
  • José Angel Campos-Sandoval, Clara Redondo, Gemma K Kinsella, Akos Pal, Geraint Jones, Gwen S Eyre, Simon C Hirst, John B C Findlay. Fenretinide derivatives act as disrupters of interactions of serum retinol binding protein (sRBP) with transthyretin and the sRBP receptor. Journal of medicinal chemistry. 2011 Jul; 54(13):4378-87. doi: 10.1021/jm200256g. [PMID: 21591606]
  • Jason P Cooper, Kyunghwa Hwang, Hardeep Singh, Dong Wang, C Patrick Reynolds, Robert W Curley, Simon C Williams, Barry J Maurer, Min H Kang. Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure. British journal of pharmacology. 2011 Jul; 163(6):1263-75. doi: 10.1111/j.1476-5381.2011.01310.x. [PMID: 21391977]
  • H-Y Ou, H-T Wu, Y-C Yang, J-S Wu, J-T Cheng, C-J Chang. Elevated retinol binding protein 4 contributes to insulin resistance in spontaneously hypertensive rats. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2011 May; 43(5):312-8. doi: 10.1055/s-0031-1271746. [PMID: 21365528]
  • Sang Woo Oh, Cheol-Young Park, Eun Sook Lee, Yeong Sook Yoon, Eon Sook Lee, Sang Shin Park, Yuil Kim, Nak Jin Sung, Young Ho Yun, Keun Seok Lee, Han Sung Kang, Youngmee Kwon, Jungsil Ro. Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast cancer research : BCR. 2011 Mar; 13(2):R34. doi: 10.1186/bcr2856. [PMID: 21450081]
  • Margaret A Park, Hossein A Hamed, Clint Mitchell, Nichola Cruickshanks, Rupesh Dash, Jeremy Allegood, Igor P Dmitriev, Gary Tye, Besim Ogretmen, Sarah Spiegel, Adly Yacoub, Steven Grant, David T Curiel, Paul B Fisher, Paul Dent. A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels. Molecular pharmacology. 2011 Mar; 79(3):368-80. doi: 10.1124/mol.110.069484. [PMID: 21119025]
  • Shivaani Kummar, Martin E Gutierrez, Barry J Maurer, C Patrick Reynolds, Min Kang, Hardeep Singh, Sonja Crandon, Anthony J Murgo, James H Doroshow. Phase I trial of fenretinide lym-x-sorb oral powder in adults with solid tumors and lymphomas. Anticancer research. 2011 Mar; 31(3):961-6. doi: NULL. [PMID: 21498721]
  • N A Illingworth, A V Boddy, A K Daly, G J Veal. Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases. British journal of pharmacology. 2011 Feb; 162(4):989-99. doi: 10.1111/j.1476-5381.2010.01104.x. [PMID: 21054342]
  • Wei-Ching Huang, Chia-Ling Chen, Yee-Shin Lin, Chiou-Feng Lin. Apoptotic sphingolipid ceramide in cancer therapy. Journal of lipids. 2011; 2011(?):565316. doi: 10.1155/2011/565316. [PMID: 21490804]
  • Gabriella Wojewodka, Juan B De Sanctis, Danuta Radzioch. Ceramide in cystic fibrosis: a potential new target for therapeutic intervention. Journal of lipids. 2011; 2011(?):674968. doi: 10.1155/2011/674968. [PMID: 21490807]
  • Kacee Sims, Christopher A Haynes, Samuel Kelly, Jeremy C Allegood, Elaine Wang, Amin Momin, Martina Leipelt, Donna Reichart, Christopher K Glass, M Cameron Sullards, Alfred H Merrill. Kdo2-lipid A, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264.7 macrophages, which is essential for induction of autophagy. The Journal of biological chemistry. 2010 Dec; 285(49):38568-79. doi: 10.1074/jbc.m110.170621. [PMID: 20876532]
  • Franca Formelli, Elena Cavadini, Roberto Luksch, Alberto Garaventa, Valentina Appierto, Stefano Persiani. Relationship among pharmacokinetics and pharmacodynamics of fenretinide and plasma retinol reduction in neuroblastoma patients. Cancer chemotherapy and pharmacology. 2010 Oct; 66(5):993-8. doi: 10.1007/s00280-010-1370-5. [PMID: 20532509]
  • Manuela Valsecchi, Massimo Aureli, Laura Mauri, Giuditta Illuzzi, Vanna Chigorno, Alessandro Prinetti, Sandro Sonnino. Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids. Journal of lipid research. 2010 Jul; 51(7):1832-40. doi: 10.1194/jlr.m004010. [PMID: 20194109]
  • Numsen Hail, Ping Chen, Jadwiga J Kepa, Lane R Bushman, Colin Shearn. Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis. Free radical biology & medicine. 2010 Jul; 49(1):109-16. doi: 10.1016/j.freeradbiomed.2010.04.006. [PMID: 20399851]
  • Andrew S Holpuch, Garrett J Hummel, Meng Tong, Garrett A Seghi, Ping Pei, Ping Ma, Russell J Mumper, Susan R Mallery. Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies. Pharmaceutical research. 2010 Jul; 27(7):1224-36. doi: 10.1007/s11095-010-0121-y. [PMID: 20354767]
  • Ann-Charlotte Johansson, Hanna Appelqvist, Cathrine Nilsson, Katarina Kågedal, Karin Roberg, Karin Ollinger. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis : an international journal on programmed cell death. 2010 May; 15(5):527-40. doi: 10.1007/s10495-009-0452-5. [PMID: 20077016]
  • Rubèn López-Vales, Adriana Redensek, Thomas A A Skinner, Khizr I Rathore, Nader Ghasemlou, Gabriella Wojewodka, Juan DeSanctis, Danuta Radzioch, Samuel David. Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010 Mar; 30(9):3220-6. doi: 10.1523/jneurosci.5770-09.2010. [PMID: 20203181]
  • T Trarbach, M Moehler, V Heinemann, C-H Köhne, M Przyborek, C Schulz, V Sneller, G Gallant, S Kanzler. Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer. British journal of cancer. 2010 Feb; 102(3):506-12. doi: 10.1038/sj.bjc.6605507. [PMID: 20068564]
  • Bryan J Schneider, Francis P Worden, Shirish M Gadgeel, Ralph E Parchment, Collette M Hodges, James Zwiebel, Rodney L Dunn, Antoinette J Wozniak, Michael J Kraut, Gregory P Kalemkerian. Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer. Investigational new drugs. 2009 Dec; 27(6):571-8. doi: 10.1007/s10637-009-9228-6. [PMID: 19225720]
  • Valentina Appierto, Paola Tiberio, Elena Cavadini, Patrizia Casalini, Graziella Cappelletti, Franca Formelli. Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity. Molecular cancer therapeutics. 2009 Dec; 8(12):3360-8. doi: 10.1158/1535-7163.mct-09-0798. [PMID: 19996280]
  • Frederic Preitner, Nimesh Mody, Timothy E Graham, Odile D Peroni, Barbara B Kahn. Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis. American journal of physiology. Endocrinology and metabolism. 2009 Dec; 297(6):E1420-9. doi: 10.1152/ajpendo.00362.2009. [PMID: 19826103]
  • Xin Li, Wen Ling, Angela Pennisi, Sharmin Khan, Shmuel Yaccoby. Fenretinide inhibits myeloma cell growth, osteoclastogenesis and osteoclast viability. Cancer letters. 2009 Nov; 284(2):175-81. doi: 10.1016/j.canlet.2009.04.022. [PMID: 19446953]
  • Evelyn Gassert, Elita Avota, Harry Harms, Georg Krohne, Erich Gulbins, Sibylle Schneider-Schaulies. Induction of membrane ceramides: a novel strategy to interfere with T lymphocyte cytoskeletal reorganisation in viral immunosuppression. PLoS pathogens. 2009 Oct; 5(10):e1000623. doi: 10.1371/journal.ppat.1000623. [PMID: 19834551]
  • S Karmakar, S Roy Choudhury, N L Banik, S K Ray. Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenografts. Neuroscience. 2009 Sep; 163(1):286-95. doi: 10.1016/j.neuroscience.2009.06.037. [PMID: 19540315]
  • Orzala Sharif, Huiyong Hu, Heath Klock, Eric N Hampton, Edward Nigoghossian, Mark W Knuth, Jason Matzen, Paul Anderson, Richard Trager, Tetsuo Uno, Richard J Glynne, Sassan M Azarian, Jeremy S Caldwell, Achim Brinker. Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4. Analytical biochemistry. 2009 Sep; 392(2):162-8. doi: 10.1016/j.ab.2009.05.038. [PMID: 19482004]
  • Andrea Decensi, Chris Robertson, Aliana Guerrieri-Gonzaga, Davide Serrano, Massimiliano Cazzaniga, Serena Mora, Marcella Gulisano, Harriet Johansson, Viviana Galimberti, Enrico Cassano, Simona M Moroni, Franca Formelli, Ernst A Lien, Giuseppe Pelosi, Karen A Johnson, Bernardo Bonanni. Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Aug; 27(23):3749-56. doi: 10.1200/jco.2008.19.3797. [PMID: 19597031]
  • Claudine Guilbault, Gabriella Wojewodka, Zienab Saeed, Marian Hajduch, Elias Matouk, Juan B De Sanctis, Danuta Radzioch. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide. American journal of respiratory cell and molecular biology. 2009 Jul; 41(1):100-6. doi: 10.1165/rcmb.2008-0279oc. [PMID: 19059886]
  • Cinzia Di Pietro, Marco Ragusa, Davide Barbagallo, Laura R Duro, Maria R Guglielmino, Alessandra Majorana, Rosario Angelica, Marina Scalia, Luisa Statello, Loredana Salito, Luisa Tomasello, Salvo Pernagallo, Salvo Valenti, Vito D'Agostino, Patrizio Triberio, Igor Tandurella, Giuseppe A Palumbo, Piera La Cava, Viviana Cafiso, Taschia Bertuccio, Maria Santagati, Giovanni Li Destri, Salvatore Lanzafame, Francesco Di Raimondo, Stefania Stefani, Bud Mishra, Michele Purrello. The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma. BMC medical genomics. 2009 Apr; 2(?):20. doi: 10.1186/1755-8794-2-20. [PMID: 19402918]
  • Peter Coward, Marion Conn, Jie Tang, Fei Xiong, Anthony Menjares, Jeff D Reagan. Application of an allosteric model to describe the interactions among retinol binding protein 4, transthyretin, and small molecule retinol binding protein 4 ligands. Analytical biochemistry. 2009 Jan; 384(2):312-20. doi: 10.1016/j.ab.2008.09.051. [PMID: 18952041]
  • Franca Formelli, Elisabetta Meneghini, Elena Cavadini, Tiziana Camerini, Maria G Di Mauro, Giuseppe De Palo, Umberto Veronesi, Franco Berrino, Andrea Micheli. Plasma retinol and prognosis of postmenopausal breast cancer patients. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009 Jan; 18(1):42-8. doi: 10.1158/1055-9965.epi-08-0496. [PMID: 19124479]
  • William N William, J Jack Lee, Scott M Lippman, Jack W Martin, Nitin Chakravarti, Hai T Tran, Anita L Sabichi, Edward S Kim, Lei Feng, Reuben Lotan, Vassiliki A Papadimitrakopoulou. High-dose fenretinide in oral leukoplakia. Cancer prevention research (Philadelphia, Pa.). 2009 Jan; 2(1):22-6. doi: 10.1158/1940-6207.capr-08-0100. [PMID: 19139014]
  • Eric Cheung, Jacek Pinski, Tanya Dorff, Susan Groshen, David I Quinn, C Patrick Reynolds, Barry J Maurer, Primo N Lara, Denice D Tsao-Wei, Przemyslaw Twardowski, Gurkamal Chatta, Mark McNamara, David R Gandara. Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial. Clinical genitourinary cancer. 2009 Jan; 7(1):43-50. doi: 10.3816/cgc.2009.n.008. [PMID: 19213668]
  • Daniela Di Paolo, Monica Loi, Fabio Pastorino, Chiara Brignole, Danilo Marimpietri, Pamela Becherini, Irene Caffa, Alessia Zorzoli, Renato Longhi, Cristina Gagliani, Carlo Tacchetti, Angelo Corti, Theresa M Allen, Mirco Ponzoni, Gabriella Pagnan. Liposome-mediated therapy of neuroblastoma. Methods in enzymology. 2009; 465(?):225-49. doi: 10.1016/s0076-6879(09)65012-6. [PMID: 19913170]
  • Harriet Johansson, Sara Gandini, Aliana Guerrieri-Gonzaga, Simona Iodice, Massimiliano Ruscica, Bernardo Bonanni, Marcella Gulisano, Paolo Magni, Franca Formelli, Andrea Decensi. Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer. Cancer research. 2008 Nov; 68(22):9512-8. doi: 10.1158/0008-5472.can-08-0553. [PMID: 19010927]
  • Michael F Marmor, Atul Jain, Darius Moshfeghi. Total rod ERG suppression with high dose compassionate Fenretinide usage. Documenta ophthalmologica. Advances in ophthalmology. 2008 Nov; 117(3):257-61. doi: 10.1007/s10633-008-9132-y. [PMID: 18523815]
  • Franca Formelli, Elena Cavadini, Roberto Luksch, Alberto Garaventa, Maria Grazia Villani, Valentina Appierto, Stefano Persiani. Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide. Cancer chemotherapy and pharmacology. 2008 Sep; 62(4):655-65. doi: 10.1007/s00280-007-0649-7. [PMID: 18066548]
  • Sarah T Pruett, Anatoliy Bushnev, Kerri Hagedorn, Madhura Adiga, Christopher A Haynes, M Cameron Sullards, Dennis C Liotta, Alfred H Merrill. Biodiversity of sphingoid bases ('sphingosines') and related amino alcohols. Journal of lipid research. 2008 Aug; 49(8):1621-39. doi: 10.1194/jlr.r800012-jlr200. [PMID: 18499644]
  • Samantha K Hutchison, Cheryce Harrison, Nigel Stepto, Caroline Meyer, Helena J Teede. Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome. Diabetes care. 2008 Jul; 31(7):1427-32. doi: 10.2337/dc07-2265. [PMID: 18390799]
  • José Manuel Fernández-Real, José María Moreno, Wifredo Ricart. Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload. Diabetes. 2008 Jul; 57(7):1918-25. doi: 10.2337/db08-0041. [PMID: 18426863]
  • Zienab Saeed, Claudine Guilbault, Juan B De Sanctis, Jennifer Henri, Dominique Marion, René St-Arnaud, Danuta Radzioch. Fenretinide prevents the development of osteoporosis in Cftr-KO mice. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 2008 May; 7(3):222-30. doi: 10.1016/j.jcf.2007.09.001. [PMID: 17988958]
  • Parameswaran G Sreekumar, Jiehao Zhou, Joonhong Sohn, Christine Spee, Stephen J Ryan, Barry J Maurer, Ram Kannan, David R Hinton. N-(4-hydroxyphenyl) retinamide augments laser-induced choroidal neovascularization in mice. Investigative ophthalmology & visual science. 2008 Mar; 49(3):1210-20. doi: 10.1167/iovs.07-0667. [PMID: 18326751]
  • James I Lee, Vu T Nguyen, Mei-Ling Chen, Peter C Adamson. A rapid, sensitive and selective liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry method for determination of fenretinide (4-HPR) in plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2008 Feb; 862(1-2):64-71. doi: 10.1016/j.jchromb.2007.10.044. [PMID: 18032119]
  • Claudine Guilbault, Juan B De Sanctis, Gabriella Wojewodka, Zienab Saeed, Claude Lachance, Thomas A A Skinner, Regina M Vilela, Stan Kubow, Larry C Lands, Marian Hajduch, Elias Matouk, Danuta Radzioch. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis. American journal of respiratory cell and molecular biology. 2008 Jan; 38(1):47-56. doi: 10.1165/rcmb.2007-0036oc. [PMID: 17656682]
  • Dimitrios G Fatouros, Ditte M Karpf, Flemming S Nielsen, Anette Mullertz. Clinical studies with oral lipid based formulations of poorly soluble compounds. Therapeutics and clinical risk management. 2007 Aug; 3(4):591-604. doi: ". [PMID: 18472981]
  • Andrea Micheli, Elisabetta Meneghini, Giorgio Secreto, Franco Berrino, Elisabetta Venturelli, Adalberto Cavalleri, Tiziana Camerini, Maria G Di Mauro, Elena Cavadini, Giuseppe De Palo, Umberto Veronesi, Franca Formelli. Plasma testosterone and prognosis of postmenopausal breast cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Jul; 25(19):2685-90. doi: 10.1200/jco.2006.09.0118. [PMID: 17548841]
  • Amit Kokate, Xiaoling Li, Bhaskara Jasti. Transport of a novel anti-cancer agent, fenretinide across Caco-2 monolayers. Investigational new drugs. 2007 Jun; 25(3):197-203. doi: 10.1007/s10637-006-9026-3. [PMID: 17146731]
  • Barry J Maurer, Ondrej Kalous, David W Yesair, Xiaqin Wu, Jitka Janeba, Vanessa Maldonado, Vazgen Khankaldyyan, Tomas Frgala, Bee-Chun Sun, R Travis McKee, Stephen W Burgess, Walter A Shaw, C Patrick Reynolds. Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 May; 13(10):3079-86. doi: 10.1158/1078-0432.ccr-06-1889. [PMID: 17505011]
  • Haojie Li, Meir J Stampfer, J Bruce W Hollis, Lorelei A Mucci, J Michael Gaziano, David Hunter, Edward L Giovannucci, Jing Ma. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS medicine. 2007 Mar; 4(3):e103. doi: 10.1371/journal.pmed.0040103. [PMID: 17388667]
  • Rainer Kuefer, Felicitas Genze, Waltraud Zugmaier, Richard E Hautmann, Ludwig Rinnab, Juergen E Gschwend, Marina Angelmeier, Aidee Estrada, Berthold Buechele. Antagonistic effects of sodium butyrate and N-(4-hydroxyphenyl)-retinamide on prostate cancer. Neoplasia (New York, N.Y.). 2007 Mar; 9(3):246-53. doi: 10.1593/neo.06766. [PMID: 17401464]
  • G J Veal, M Cole, J Errington, A D J Pearson, A B M Foot, G Whyman, A V Boddy. Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma - a study of the United Kingdom Children's Cancer Study Group. British journal of cancer. 2007 Feb; 96(3):424-31. doi: 10.1038/sj.bjc.6603554. [PMID: 17224928]
  • Suryakant K Niture, Chinavenmani S Velu, Quentin R Smith, G Jayarama Bhat, Kalkunte S Srivenugopal. Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines. Carcinogenesis. 2007 Feb; 28(2):378-89. doi: 10.1093/carcin/bgl155. [PMID: 16950796]
  • Robert C Bast, Molly Brewer, Changping Zou, Mary A Hernandez, Mary Daley, Robert Ozols, Karen Lu, Zhen Lu, Donna Badgwell, Gordon B Mills, Steven Skates, Zhen Zhang, Dan Chan, Anna Lokshin, Yinhua Yu. Prevention and early detection of ovarian cancer: mission impossible?. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 2007; 174(?):91-100. doi: 10.1007/978-3-540-37696-5_9. [PMID: 17302189]
  • Sherimay Ablan, Satinder S Rawat, Mathias Viard, Ji Ming Wang, Anu Puri, Robert Blumenthal. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion. Virology journal. 2006 Dec; 3(?):104. doi: 10.1186/1743-422x-3-104. [PMID: 17187670]
  • Ann B Goodman. Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease. Journal of cellular physiology. 2006 Dec; 209(3):598-603. doi: 10.1002/jcp.20784. [PMID: 17001693]
  • Morris Pollard, Mark A Suckow. Dietary prevention of hormone refractory prostate cancer in Lobund-Wistar rats: a review of studies in a relevant animal model. Comparative medicine. 2006 Dec; 56(6):461-7. doi: NULL. [PMID: 17219775]
  • Nicoletta Colombo, Franca Formelli, Maria Grazia Cantù, Gabriella Parma, Milena Gasco, Alessandra Argusti, Alfredo Santinelli, Rodolfo Montironi, Elena Cavadini, Laura Baglietto, Aliana Guerrieri-Gonzaga, Giuseppe Viale, Andrea Decensi. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006 Oct; 15(10):1914-9. doi: 10.1158/1055-9965.epi-06-0183. [PMID: 17035399]
  • Noriko Takahashi, Toshihiro Ohba, Takayasu Yamauchi, Kimio Higashiyama. Antioxidant and anticancer activities of novel p-alkylaminophenols and p-acylaminophenols (aminophenol analogues). Bioorganic & medicinal chemistry. 2006 Sep; 14(17):6089-96. doi: 10.1016/j.bmc.2006.05.013. [PMID: 16725328]
  • Judith G Villablanca, Mark D Krailo, Matthew M Ames, Joel M Reid, Gregory H Reaman, C Patrick Reynolds, Patrick C Reynolds. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Jul; 24(21):3423-30. doi: 10.1200/jco.2005.03.9271. [PMID: 16849757]
  • Masami Suganuma, Miki Kurusu, Kaori Suzuki, Emi Tasaki, Hirota Fujiki. Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene. International journal of cancer. 2006 Jul; 119(1):33-40. doi: 10.1002/ijc.21809. [PMID: 16463383]
  • Weihong Yin, Satish Cheepala, Jennifer N Roberts, Keith Syson-Chan, John DiGiovanni, John L Clifford. Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions. Molecular cancer. 2006 Apr; 5(?):15. doi: 10.1186/1476-4598-5-15. [PMID: 16603078]
  • Morando Soffritti, Fiorella Belpoggi, Davide Degli Esposti, Luca Lambertini, Eva Tibaldi, Anna Rigano. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats. Environmental health perspectives. 2006 Mar; 114(3):379-85. doi: 10.1289/ehp.8711. [PMID: 16507461]
  • Catherine M Finnegan, Robert Blumenthal. Fenretinide inhibits HIV infection by promoting viral endocytosis. Antiviral research. 2006 Feb; 69(2):116-23. doi: 10.1016/j.antiviral.2005.11.002. [PMID: 16375981]
  • Noriko Takahashi, Toshio Honda, Toshihiro Ohba. Anticancer and superoxide scavenging activities of p-alkylaminophenols having various length alkyl chains. Bioorganic & medicinal chemistry. 2006 Jan; 14(2):409-17. doi: 10.1016/j.bmc.2005.08.016. [PMID: 16203149]
  • Roxana A Radu, Yun Han, Tam V Bui, Steven Nusinowitz, Dean Bok, Jay Lichter, Ken Widder, Gabriel H Travis, Nathan L Mata. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Investigative ophthalmology & visual science. 2005 Dec; 46(12):4393-401. doi: 10.1167/iovs.05-0820. [PMID: 16303925]
  • Doris M Benbrook, Scott A Kamelle, Suresh B Guruswamy, Stan A Lightfoot, Teresa L Rutledge, Natalie S Gould, Bethany N Hannafon, S Terence Dunn, K Darrell Berlin. Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists. Investigational new drugs. 2005 Oct; 23(5):417-28. doi: 10.1007/s10637-005-2901-5. [PMID: 16133793]
  • Da-ming Zou, Molly Brewer, Francisco Garcia, Jean M Feugang, Jian Wang, Roungyu Zang, Huaguang Liu, Changping Zou. Cactus pear: a natural product in cancer chemoprevention. Nutrition journal. 2005 Sep; 4(?):25. doi: 10.1186/1475-2891-4-25. [PMID: 16150152]
  • Qin Yang, Timothy E Graham, Nimesh Mody, Frederic Preitner, Odile D Peroni, Janice M Zabolotny, Ko Kotani, Loredana Quadro, Barbara B Kahn. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005 Jul; 436(7049):356-62. doi: 10.1038/nature03711. [PMID: 16034410]
  • Ulka Vaishampayan, Lance K Heilbrun, Ralph E Parchment, Vikash Jain, James Zwiebel, Ramesh R Boinpally, Patricia LoRusso, Maha Hussain. Phase II trial of fenretinide in advanced renal carcinoma. Investigational new drugs. 2005 Mar; 23(2):179-85. doi: 10.1007/s10637-005-5864-7. [PMID: 15744595]
  • Vinay K Puduvalli, W K Alfred Yung, Kenneth R Hess, John G Kuhn, Morris D Groves, Victor A Levin, James Zwiebel, Susan M Chang, Timothy F Cloughesy, Larry Junck, Patrick Wen, Frank Lieberman, Charles A Conrad, Mark R Gilbert, Christina A Meyers, Vivien Liu, Minesh P Mehta, M Kelly Nicholas, Michael Prados. Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Nov; 22(21):4282-9. doi: 10.1200/jco.2004.09.096. [PMID: 15514370]
  • Maria Grazia Villani, Valentina Appierto, Elena Cavadini, Manuela Valsecchi, Sandro Sonnino, Robert W Curley, Franca Formelli. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Sep; 10(18 Pt 1):6265-75. doi: 10.1158/1078-0432.ccr-04-0655. [PMID: 15448016]
  • Penny E Lovat, Federica Di Sano, Marco Corazzari, Barbara Fazi, Raffaele Perrone Donnorso, Andy D J Pearson, Andrew G Hall, Christopher P F Redfern, Mauro Piacentini. Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide. Journal of the National Cancer Institute. 2004 Sep; 96(17):1288-99. doi: 10.1093/jnci/djh254. [PMID: 15339967]
  • Hye-Sook Han, Youn-Ja Kwon, Si-Ho Park, Eun-Joo Kim, Young-Soy Rho, Hong-Sig Sin, Soo-Jong Um. Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cells. International journal of cancer. 2004 Mar; 109(1):58-64. doi: 10.1002/ijc.11643. [PMID: 14735468]
  • Jason S Chapman, Kevin L Weiss, Robert W Curley, Margaret A Highland, Margaret Clagett-Dame. Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis. Archives of biochemistry and biophysics. 2003 Nov; 419(2):234-43. doi: 10.1016/j.abb.2003.09.001. [PMID: 14592467]
  • Federica Cheli, Ioannis Politis, Luciana Rossi, Eleonora Fusi, Antonella Baldi. Effects of retinoids on proliferation and plasminogen activator expression in a bovine mammary epithelial cell line. The Journal of dairy research. 2003 Nov; 70(4):367-72. doi: 10.1017/s0022029903006496. [PMID: 14649406]
  • Andrea Decensi, Umberto Veronesi, Rosalba Miceli, Harriet Johansson, Luigi Mariani, Tiziana Camerini, Maria Gaetana Di Mauro, Elena Cavadini, Giuseppe De Palo, Alberto Costa, Marjorie Perloff, Winfred F Malone, Franca Formelli. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Oct; 9(13):4722-9. doi: NULL. [PMID: 14581342]
  • Soo-Jong Um, Hong-Sig Sin, Hye-Sook Han, Youn-Ja Kwon, Eun-Joo Kim, Si-Ho Park, Sun-Young Kim, Tae-Sung Bae, Jong-Sup Park, Young-Soy Rho. Potent cytotoxic effects of novel retinamide derivatives in ovarian cancer cells. Biological & pharmaceutical bulletin. 2003 Oct; 26(10):1412-7. doi: 10.1248/bpb.26.1412. [PMID: 14519946]
  • Anita L Sabichi, Manual R Modiano, J Jack Lee, Yei-Mei Peng, Ming-Jing Xu, Hugo Villar, William S Dalton, Scott M Lippman. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Jul; 9(7):2400-5. doi: NULL. [PMID: 12855611]
  • Alberto Garaventa, Roberto Luksch, Maria Serena Lo Piccolo, Elena Cavadini, Paolo G Montaldo, Maria Rosa Pizzitola, Luca Boni, Mirco Ponzoni, Andrea Decensi, Bruno De Bernardi, Franca Fossati Bellani, Franca Formelli. Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Jun; 9(6):2032-9. doi: NULL. [PMID: 12796365]
  • Kyung-Hee Chun, Jerome W Kosmeder, Shihua Sun, John M Pezzuto, Reuben Lotan, Waun Ki Hong, Ho-Young Lee. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. Journal of the National Cancer Institute. 2003 Feb; 95(4):291-302. doi: 10.1093/jnci/95.4.291. [PMID: 12591985]
  • Franca Formelli, Tiziana Camerini, Elena Cavadini, Valentina Appierto, Maria Grazia Villani, Alberto Costa, Giuseppe De Palo, Maria Gaetana Di Mauro, Umberto Veronesi. Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2003 Jan; 12(1):34-41. doi: NULL. [PMID: 12540501]
  • Anat Erdreich-Epstein, Linda B Tran, Nina N Bowman, Hongtao Wang, Myles C Cabot, Donald L Durden, Jitka Vlckova, C Patrick Reynolds, Monique F Stins, Susan Groshen, Melissa Millard. Ceramide signaling in fenretinide-induced endothelial cell apoptosis. The Journal of biological chemistry. 2002 Dec; 277(51):49531-7. doi: 10.1074/jbc.m209962200. [PMID: 12388538]
  • Noriko Takahashi, Toshihiro Ohba, Shin-ichi Togashi, Tetsuya Fukui. Biological activity of p-methylaminophenol, an essential structural component of N-(4-hydroxyphenyl)retinamide, fenretinide. Journal of biochemistry. 2002 Nov; 132(5):767-74. doi: 10.1093/oxfordjournals.jbchem.a003285. [PMID: 12417027]
  • Hongtao Wang, Armando E Giuliano, Myles C Cabot. Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells. Molecular cancer therapeutics. 2002 Jul; 1(9):719-26. doi: ". [PMID: 12479368]
  • A Asumendi, M C Morales, A Alvarez, J Aréchaga, G Pérez-Yarza. Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl)retinamide-induced apoptosis. British journal of cancer. 2002 Jun; 86(12):1951-6. doi: 10.1038/sj.bjc.6600356. [PMID: 12085192]
  • Amanda H Prowse, Lisa Vanderveer, Simon W F Milling, Zhong-Zong Pan, Roland L Dunbrack, Xiang-Xi Xu, Andrew K Godwin. OVCA2 is downregulated and degraded during retinoid-induced apoptosis. International journal of cancer. 2002 May; 99(2):185-92. doi: 10.1002/ijc.10334. [PMID: 11979432]
  • Cristina Rodríguez-Burford, Vernon E Steele, Amy S Anderson, Cecil R Stockard, Heidi L Weiss, Isao Eto, Gary L Johanning, William E Grizzle, Clinton J Grubbs. Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology. Nutrition and cancer. 2002; 43(1):67-75. doi: 10.1207/s15327914nc431_8. [PMID: 12467137]